Stool samples is named as an intervention in 4 current clinical trials in our France and Norway registers. 3 are recruiting patients now. The most common phase is Observational. The sponsor with the most trials is Assistance Publique - Hôpitaux de Paris (2). The most-studied condition is Activated PI3K Delta Syndrome.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome
NCT06694363 · ClinicalTrials.gov ↗ · Activated PI3K Delta Syndrome
|
Observational | Recruiting | Assistance Publique - Hôpitaux de Paris | France |
|
Memory Deterioration in Alzheimer Disease
NCT07118137 · ClinicalTrials.gov ↗ · Alzheimer Disease, Neurodegenerative Diseases, Magnetic Resonance Imaging
|
Observational | Recruiting | Norwegian University of Science and Technology | Norway |
|
Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: Netherton Syndrome
NCT07280091 · ClinicalTrials.gov ↗ · Netherton Syndrome
|
Observational | Recruiting | Assistance Publique - Hôpitaux de Paris | France |
|
Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis
NCT07078435 · ClinicalTrials.gov ↗ · Endometriosis, Immunity, Microbiota
|
Not applicable | Not yet open | University Hospital, Grenoble | France |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| University Hospital, Grenoble | 1 |
| Norwegian University of Science and Technology | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in France | 3 | 2 |
| Clinical trials in Norway | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
4 current trials in our France and Norway registers name Stool samples as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 3 of the 4 trials are recruiting: 2 with sites in France and 1 with sites in Norway. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Assistance Publique - Hôpitaux de Paris (2), University Hospital, Grenoble (1) and Norwegian University of Science and Technology (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Stool samples works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Stool samples works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Stool samples (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.